DUBLIN--(BUSINESS WIRE)--Aug 13, 2019--

The North American pharmaceutical desiccant market is expected to surge with 4.64% of CAGR in the estimated period from 2019-2027.

The countries of the US and Canada form the market for pharmaceutical desiccant in the North American region.

The US FDA is regarded as one of the best regulatory bodies in the world. Product approvals are fast, with a median time of around 13 months. The only major drawback in the approvals process is the recently defined pathway for biosimilars, which allows for interchangeability, but this is yet to be tested by an approval. The reimbursement system - or widespread lack thereof - in the US is a major drawback.

On the other hand, the country's free pricing policy is a major benefit to the industry. Healthcare spending growth in the US is expected to outpace economic expansion over the medium term slightly. The US patented drugs market is the most dynamic sub-sector of the overall pharmaceutical market, with dozens of new products launched every year. These innovative medicines slowly gain traction with prescribers as evidence of their clinical utility is gathered, and several become multi-billion dollar franchises. Conversely, once patents expire, sales drop sharply in the face of generic erosion.

Competitive Outlook

The biggest brands in the market are Multisorb Technologies, Desiccare, Inc., Munters AB, E. I. du Pont de Nemours and Company, ProFlute AB and Oker-Chemie GmbH.

Key Topics Covered:

1. North America Pharmaceutical Desiccant Market - Summary

2. Industry Outlook

2.1. Market Definition

2.2. Porter's Five Forces Analysis

2.3. Vendor Scorecard

2.4. Supply Chain Analysis

2.5. Key Insight

2.6. Market Drivers

2.6.1. Increasing Geriatric Population

2.6.2. Government Initiatives Taken to Ensure Quality of Drugs

2.6.3. Continuous Growth in the Pharmaceutical Industry

2.7. Market Restraints

2.7.1. Variable Temperatures Hamper Pharmaceutical Products

2.7.2. Stringent Regulations

2.8. Market Opportunities

2.8.1. Establishment of Stronger Presence in Varying Consumer Preferences

2.9. Market Challenges

2.9.1. Growing Customer Expectancies

2.9.2. Pricing is Market-Based Rather Than Cost-Based

3. Pharmaceutical Desiccant Market Outlook - By Types

3.1. Silica Gel

3.2. Activated Alumina

3.3. Carbonclay Desiccant

3.4. Molecular Sieves

3.5. Other Types

4. Pharmaceutical Desiccant Market Outlook - By End-Users

4.1. Tablets

4.2. Apis

4.3. Capsules

4.4. Nutraceutical Product Packaging

4.5. Diagnostic Kits

5. Pharmaceutical Desiccant Market - Regional Outlook

5.1. North America

5.1.1. Country Analysis

5.1.1.1. the United States

5.1.1.2. Canada

6. Company Profiles

6.1. Capitol Scientific, Inc.

6.2. Clariant North America

6.3. Csp Technologies, Inc.

6.4. Desiccare, Inc.

6.5. E. I. Du Pont De Nemours And Company

6.6. Multisorb Technologies

6.7. Munters Ab

6.8. Oker-Chemie Gmbh

6.9. Proflute Ab

6.10. Rotor Source, Inc.

6.11. Sanner Gmbh

6.12. W. R. Grace & Co.

For more information about this report visit https://www.researchandmarkets.com/r/mnbrc4

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD: NORTH AMERICA

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 08/13/2019 10:01 AM/DISC: 08/13/2019 10:01 AM

Copyright Business Wire 2019.

Locations